Company information:
Nevrargenics Limited (No: 12369627)
Address: UNIT 31A OUSE HOUSE MANDALE PARK, BELMONT INDUSTRIAL ESTATE, DURHAM, DH1 1TT, ENGLAND
Status: Active
Incorporated: 18-Dec-2019
Accounts Next Due: 30-Sep-2025
Next Confirmation Statement Due: 02-Jun-2025
Industry Class: 72110 - Research and experimental development on biotechnology
Current Director: JAMES CLAUDE BROMHEAD ( DOB: Aug-1961 From: Jun-2021 )
Current Director: JAMES CLAUDE BROMHEAD ( DOB: Aug-1961 From: Jun-2021 )
Current Director: DIMITRI DIMITRIOU ( DOB: Mar-1961 From: Aug-2021 )
Current Director: MAXWELL EUAN NOBLE ( DOB: Sep-1966 From: Jun-2021 )
Current Director: ANDREW WHITING ( DOB: Aug-1960 From: Dec-2019 )
Persons of Significant Control:
University Of Durham, The Palatine Centre Stockton Road, Durham, County Durham, DH1 3LE, United Kingdom: Ownership of shares – 75% or more as a member of a firm, Ownership of voting rights - 75% or more as a member of a firm (Notified: 2019-12-18, Ceased: 2021-06-16)
Company Accounts Summary (£)
| Item | 2020-12 | 2021-12 | 2022-12 | 2023-12 | Chart |
|---|---|---|---|---|---|
| Called up share capital not paid, not expressed as current asset | 1 | 1.0,0.0,0.0,0.0 | |||
| Net assets (liabilities) | 1 | -970 | 1.0,-970.0,0.0,0.0 | ||
| Equity / share capital and reserves | 1 | -970 | 236,591 | -45,796 | 1.0,-970.0,236591.0,-45796.0 |